Study of Intranasal Dexmedetomidine plus Ketamine Compared to Intravenous Ketamine for Sedation in Children with Fractures or Dislocations
Led by Naveen Poonai · Updated on 2024-11-05
400
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate sedation approaches for children with orthopedic injuries requiring procedural sedation in emergency departments. It focuses on comparing a combination of intranasal dexmedetomidine and ketamine IN Ketodex to the standard intravenous ketamine sedation. The study is a multi-center, randomized, blinded, controlled, non-inferiority trial designed to determine if IN Ketodex provides sedation as effectively as IV ketamine, potentially offering a less painful alternative for children who often experience distress from IV insertion.
Participants receive one of several study treatments three different doses of IN Ketodex combining dexmedetomidine and ketamine administered intranasally with a mucosal atomizer device, alongside a small intravenous saline placebo or intravenous ketamine with intranasal saline placebo. The intranasal treatments vary in dosing levels to identify the most effective and tolerable combination. The trial includes dosing limits and delivery methods carefully defined to assess sedation depth and patient experience.
Children aged 2 to 17 years with specific closed fractures or dislocations will participate in the study. Researchers will monitor sedation depth using the Pediatrics Sedation State Scale during the emergency department visit, lasting up to four hours. They will also assess length of stay, time to waking, and adverse effects up to 72 hours after discharge. The study tracks safety and effectiveness measures closely, aiming to improve procedural sedation options for pediatric orthopedic injuries.
CONDITIONS
Brief Title
Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation
Research Team
N
Naveen Poonai, MD
K
Kamary Coriolano, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Willingness to comply with all study procedures and available for the study duration
Deemed by treating physician to require procedural sedation
Age 2 to 17 years
Weighing up to 100 kg
Have one of the following injuries: closed forearm fracture, metacarpal or finger fracture, shoulder or elbow dislocation, or type II supracondylar fracture
Expected to need only one dose of IV sedative medication if not in the trial
Both nostrils fully open
Physician plans to sedate the patient
You will not qualify if you...
Previous allergic reaction to ketamine or dexmedetomidine
Suspected rupture of the eye globe
Traumatic brain injury with bleeding in the brain
Uncontrolled high blood pressure
Nasal bone deformity or septal deviation
Poor English or French without interpreter
American Society of Anesthesiologists (ASA) class 3 or higher
Past diagnosis of schizophrenia or active psychosis
Neuro-cognitive impairment preventing consent or self-reporting
More than one fracture or dislocation needing reduction
Hemodynamic instability
Glasgow coma score less than 15
Sedation with ketamine or hematoma block within 24 hours
Comminuted fracture or fracture with dislocation
Hematoma block within 24 hours
Obstructive sleep apnea
Previous enrollment in this trial
Suspected pregnancy
Congenital heart disease or known heart rhythm problems
Known or suspected liver impairment
Known kidney problems
Uncorrected mineralocorticoid deficiency
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Single day
Participants receive a single dose of intranasal dexmedetomidine plus ketamine or intravenous ketamine for procedural sedation to manage orthopedic injuries.
1 treatment visit in the emergency department
Follow-up
Duration - Up to 72 hours post-discharge
Participants are monitored for adverse effects and recovery after sedation during their stay in the emergency department and up to 72 hours post-discharge.
1 to 2 follow-up contacts or visits after discharge
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Similar Trials
Comparing Buprenorphine and Hydromorphone for Pain Relief in Older Adults with Broken Bones in the Emergency Department
A One-Month Study of Cannabidiol CBD for Pain and Inflammation Relief After Long Bone Fracture
Study of DePuy Synthes Variable Angle Clavicle Plate and Hook Plate 2.7 Systems for Fixing Clavicle Fractures and AC Joint Dislocations
Outcomes of the Medacta Shoulder System for Various Shoulder Conditions Including Osteoarthritis and Rotator Cuff Tear Arthropathy
Evaluating Nanox.ARC Digital Tomosynthesis for Diagnosing Musculoskeletal Conditions in Adults
Long-Term Evaluation of Shoulder Arthroplasty Clinical and Radiographic Outcomes
An Open-Label, Multi-Center Observational Study
Study of Fragility Fracture Liaison and Anti-Osteoporosis Medication Monitoring Services
at National Taiwan University Hospital Jinshan Branch
Study of Intranasal Dexmedetomidine plus Ketamine Compared to Intravenous Ketamine for Sedation in Children with Fractures or Dislocations
Global Follow-Up Program for Safety and Effectiveness of Pediatric Orthopaedic Implants
Comparing Oral Versus Intravenous Antibiotics for Treating Infected Nonunion Fractures After Surgical Fixation
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The intranasal dexmedetomidine plus ketamine for procedural sedation in children, adaptive randomized controlled non-inferiority multicenter trial (Ketodex): a statistical analysis plan.
Anna Heath, Juan David Rios, Eleanor Pullenayegum...